Ethyl 2-(3-cyano-4-isobutoxyphenyl)-4-methyl-5-thiazolecarboxylate: A Pharmaceutical Intermediate

Discover the vital role of this compound in advancing hyperuricemia and gout treatments.

Get a Quote & Sample

Advantages in Application

Enhanced Drug Efficacy

The precise molecular structure of this compound, crucial for Febuxostat impurity synthesis, directly impacts the efficacy of the final drug product in managing hyperuricemia.

Reliable Supply Chain

Availability from multiple global manufacturers underscores its importance in pharmaceutical intermediate manufacturing, ensuring consistent production of vital medications.

Quality Assurance

Adherence to high purity standards in chemical synthesis of gout medication is vital for patient safety and therapeutic outcomes.

Key Applications

Febuxostat Synthesis

This compound is a key intermediate in the multi-step process required for the synthesis of Febuxostat, a drug used to treat high uric acid levels.

Hyperuricemia Treatment Research

Its role in producing Febuxostat makes it essential for ongoing research into new and improved treatments for hyperuricemia and related conditions.

Pharmaceutical Impurity Standards

As an identified impurity or intermediate, it is used as a reference standard for quality control in pharmaceutical manufacturing, ensuring product purity.

Chemical Building Blocks

It serves as a versatile building block in organic chemistry, enabling the creation of complex molecules for various scientific and industrial applications.